Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Meeting

---
identifier: "/us/fr/05-9987"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Meeting"
title_number: 0
title_name: "Federal Register"
section_number: "05-9987"
section_name: "Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Meeting"
positive_law: false
currency: "2005-05-19"
last_updated: "2005-05-19"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "05-9987"
document_type: "notice"
publication_date: "2005-05-19"
agencies:
  - "Health and Human Services Department"
  - "Centers for Disease Control and Prevention"
fr_citation: "70 FR 28946"
fr_volume: 70
---


#  Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Meeting

In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the following meeting:

*Name:* Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Antimalarial Drug Resistance and Prevention of Malaria During Pregnancy CI05-061, Linkage of International Collaboration and Research Programs for Prevention and Control of Malaria, CI-05-062 and Comparisons of Community with Facility Management of Malaria and Pneumonia in Rural Tanzania, CI05-064.

*Times and Dates:* 1 p.m.-3:30 p.m., June 15, 2005 (Closed).

*Place:* Teleconference.

*Status:* Portions of the meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Pub. L. 92-463.

*Matters To Be Discussed:* The meeting will include the review, discussion, and evaluation of applications received in response to: Preventing Maternal and Neonatal Bacterial Infections in Developing Settings with a High Prevalence of HIV: Antimalarial Drug Resistance and Prevention of Malaria During Pregnancy CI05-061, Linkage of International Collaboration and Research Programs for Prevention and Control of Malaria, CI-05-062 and Comparisons of Community with Facility Management of Malaria and Pneumonia in Rural Tanzania, CI05-064.

*FOR FURTHER INFORMATION CONTACT:* Trudy Messmer, Ph.D., Scientific Review Administrator, National Center for Infectious Diseases, CDC, 1600 Clifton Road NE., Mailstop C19, Atlanta, GA 30333, Telephone (404) 639-3770.

The Director, Management Analysis and Services Office, has been delegated the authority to sign *Federal Register* notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry.

Dated: May 12, 2005.

Alvin Hall,

Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.